ADC Therapeutics

ADCT • NYSE • Stock Fundamentals

ADC Therapeutics is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Ameet Mallik, with a market cap of $134.8M.

Market Cap$134.8M

Employees274.0

CEOAmeet Mallik

CountrySwitzerland

Healthcare

Biotechnology

Most Recent EarningsMay 4, 2026 · 1 month 10 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about ADC Therapeutics

ADC Therapeutics (ADCT) has a market capitalization of $134.8M and trades on NYSE.

ADC Therapeutics has approximately 274 employees.